NELL1-based Therapeutic

About NellOne Therapeutics

NellOne Therapeutics is a private, pre-revenue biotech focused on harnessing the NELL1 signaling protein, a key regulator expressed during fetal development, to achieve true tissue regeneration and scarless healing. The company's platform technology aims to control inflammation, recruit stem cells, form new blood vessels, and restore tissue mass and function across a wide range of severe injuries and disorders. While still in the pre-clinical or early development stage, NellOne is targeting significant unmet needs in areas such as viral-induced lung injury, osteoporosis, cartilage, tendon, and muscle repair, with the goal of improving patient outcomes and reducing healthcare system burdens.

Therapeutic Areas